Bictegravir/Emtricitabine/TAF
$3,746
Avg Cost per Claim
Brand Only
Medicare Part D spent $3821M on Biktarvy across 1,020,000 claims.
View full report →Source: CMS Medicare Part D Spending, 2026.
Data from DrugPrice
Medicare Part D spent $3821M on Biktarvy across 1,020,000 claims.
View full report →Source: CMS Medicare Part D Spending, 2026.